Professor, Surgery, University of Texas Medical School at Houston
General Surgery
Dr. Raphael E. Pollock, MD
|
|
Give Review
Raphael Pollock works in the field of General Surgery. He graduated from Saint Louis University School of Medicine. Saint Louis University School of Medicine has a rank of 67 in research and a 57 in primary care He received awards:"America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Fellow (FACS)". Raphael Pollock has written publications. He has 100 publications published with PubMed. The lastest paper is: 'TGF- and CTGF are Mitogenic Output Mediators of Wnt/-Catenin Signaling in Desmoid Fibromatosis.'
Publications
- TGF-β and CTGF are Mitogenic Output Mediators of Wnt/β-Catenin Signaling in Desmoid Fibromatosis.
- Antitumor effects of pharmacological EZH2 inhibition on malignant Peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway.
- Targeting the Notch pathway: A potential therapeutic approach for desmoid tumors.
- Contemporary approaches to Sarcoma.
- Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
- Accuracy of Preoperative Percutaneous Biopsy for the Diagnosis of Retroperitoneal LipoSarcoma Subtypes.
- Locoregional Disease Patterns in Well-Differentiated and Dedifferentiated Retroperitoneal Liposarcoma: Implications for the Extent of Resection?
- Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for GastroIntestinal Stromal Tumors.
- Mesenchymal to epithelial transition in Sarcomas.
- Three-dimensional computational analysis of optical coherence tomography images for the detection of Soft tissue sarcomas.
- Assessment of multimodality therapy use for extremity Sarcoma in the United States.
- EZH2/miR-30d/KPNB1 pathway regulates malignant Peripheral nerve sheath tumor cell survival and tumorigenesis.
- Lumping, splitting, and making sense: implications of Soft tissue sarcoma staging for prognosis, therapy, and research.
- Heterogeneity and immunophenotypic plasticity of malignant cells in human lipoSarcomas.
- Complex reconstruction of desmoid tumor resections does not increase desmoid tumor recurrence.
- Long-term outcomes in patients with radiation-associated angiosarcomas of the Breast following surgery and radiotherapy for Breast cancer.
- Long telomeres in Peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma.
- Localized and metastatic myxoid/round cell lipoSarcoma: Clinical and molecular observations.
- Reduced mitochondrial DNA copy number in Peripheral blood leukocytes increases the risk of soft tissue sarcoma.
- Uterine LeiomyoSarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution's Experience.
- Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine LeiomyoSarcoma.
- Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors.
- Value-Based Health Care: A Surgical Oncologist's Perspective.
- FAP-related desmoid tumors: a series of 44 patients evaluated in a Cancer referral center.
- Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors.
- Lymphocyte Composition and Distribution in Inflammatory, Well-differentiated Retroperitoneal LipoSarcoma: Clues to a Potential Adaptive Immune Response and Therapeutic...
- Expression of concern.
- Sarcoma metastases to the skin: A clinicopathologic study of 65 patients.
- Diagnosis, management, and outcome of patients with dedifferentiated lipoSarcoma systemic metastasis.
- Pleomorphic lipoSarcoma: Clinical observations and molecular variables.
- Desmoid tumor: current multidisciplinary approaches.
- A Population-Based Study of the Quality of Care in the Diagnosis of Large (≥5 cm) Soft Tissue Sarcomas.
- Revealing retroperitoneal lipoSarcoma morphology using optical coherence tomography.
- Integrative genomic characterization and a genomic staging system for gastroIntestinal stromal tumors.
- Epithelioid Sarcoma and unclassified Sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model.
- Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyoSarcoma through regulation of slug.
- The integrity of authorship: doing the right thing.
- Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual ...
- Managing elderly Soft tissue sarcoma patients-should age drive treatment?
- AngioSarcoma: clinical and molecular insights.
- Neoadjuvant treatment of Soft-tissue sarcoma: a multimodality approach.
- Clinical outcomes of molecularly confirmed clear cell Sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Result...
- Clinical, pathological, and molecular variables predictive of malignant Peripheral nerve sheath tumor outcome.
- Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of Soft tissue sarcoma.
- Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant Peripheral nerve sheath tumor.
- Increased Vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas.
- A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.
- Establishing prognosis in retroperitoneal Sarcoma: a new histology-based paradigm.
- Multifocality in retroperitoneal Sarcoma: a prognostic factor critical to surgical decision-making.
- The role of surgical margin status in retroperitoneal Sarcoma.
- Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
- The seminal role of Cancer in our understanding of sarcoma.
- Value-based health care: the MD Anderson experience.
- Combined Vascular endothelial growth factor receptor/epidermal growth factor receptor blockade with chemotherapy for treatment of local, uterine, and metastatic soft t...
- Midkine enhances Soft-tissue sarcoma growth: a possible novel therapeutic target.
- Mortality after cure of Soft-tissue sarcoma treated with conservation surgery and radiotherapy.
- Board certification in surgical oncology: does it make sense?
- Challenges in surgical management of Abdominal pain in the neutropenic cancer patient.
- Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits Soft tissue sarcoma cell growth in vitro and in vivo.
- Lymphadenectomy for isolated lymph node metastasis from extremity Soft-tissue sarcomas.
- Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha.
- A preclinical model for predicting drug response in Soft-tissue sarcoma with targeted AAVP molecular imaging.
- Excellent local control rates and distinctive patterns of failure in myxoid lipoSarcoma treated with conservation surgery and radiotherapy.
- Surgical oncology at the crossroads: the future is now.
- Surgical oncology: training for multidisciplinary Cancer care.
- Angiogenesis-promoting gene patterns in alveolar Soft part sarcoma.
- Long-term outcomes for synovial Sarcoma treated with conservation surgery and radiotherapy.
- Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology.
- Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk Soft tissue sarcomas.
- Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with Sarcomatosis.
- High prevalence of p53 exon 4 mutations in Soft tissue sarcoma.
- Optimizing treatment of desmoid tumors.
- Rad51 overexpression contributes to chemoresistance in human Soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation.
- Management of locally recurrent Soft-tissue sarcoma after prior surgery and radiation therapy.
- Highly accurate two-gene classifier for differentiating gastroIntestinal stromal tumors and leiomyosarcomas.
- Periosteal margin in Soft-tissue sarcoma.
- Surgical resection of gastroIntestinal stromal tumors after treatment with imatinib.
- Retroperitoneal Soft tissue sarcoma: an analysis of radiation and surgical treatment.
- Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for Soft tissue sarcoma growth and metastasis.
- Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance.
- The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity Soft-tissue sarcomas.
- Staging Soft tissue sarcoma: evolution and change.
- Molecular diagnosis of Sarcomas: chromosomal translocations in Sarcomas.
- Results of a single-center experience with resection and ablation for sarcoma metastatic to the Liver.
- Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal Soft tissue sarcoma.
- Unsupervised analysis uncovers changes in histopathologic diagnosis in supervised genomic studies.
- Angiosarcoma of the Breast.
- Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyoSarcoma in vivo.
- Extremity Soft tissue sarcoma: evidence-based multidisciplinary management.
- Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial Sarcoma.
- Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation.
- Bilateral metastatic renal synovial Sarcoma.
- A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in Sarcomas and astrocytomas.
- Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two Cancer centers: chemotherapy-associated outcomes.
- Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.
- Upper extremity reconstruction following resection of Soft tissue sarcomas: a functional outcomes analysis.
- A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastroIntestinal stromal tumors.
- Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall Soft tissue sarcomas.
- Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic Soft tissue sarcoma: a combined analysis from the University of Tex...
Schools
St Louis Univ Sch Of Med
University of Chicago
Rush Presby St Lukes Hospital
Md Anderson
Procedures Preformed
- Adrenalectomy
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Biopsy of Breast
- View All
Conditions Treated
- Abdominal Pain
- Appendicitis
- Atelectasis
- Breast Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of Chicago -
Saint Louis University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center -
Ohio State University Wexner Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083719694 |
| Last Name Of The Provider | POLLOCK |
| First Name Of The Provider | RAPHAEL |
| View All |
Similar Doctors
|
Dr. Terry K. Scarborough, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Neal R. Reisman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Lawrance, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Puja Gaur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Knight, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zachary M. Griffith, MD |
|
|
Dr. Joseph F. Fernandez-Moure, MD |
|
|
Dr. Phillip A. Letourneau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yangyang Yu, MD |